These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10199101)

  • 1. More on valproate and polycystic ovaries.
    Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 3. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 4. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary observations on valproate and cystic ovaries: letter to editor.
    Chakravarty A
    Neurol India; 2002 Mar; 50(1):106-7. PubMed ID: 11960167
    [No Abstract]   [Full Text] [Related]  

  • 6. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 7. [The dangers of valproate in women].
    Isojärvi J
    Duodecim; 1998; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
    N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 11. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate and polycystic ovaries.
    Irwin M; Masand P
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):9-10. PubMed ID: 9444888
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries.
    Soares JC
    Bipolar Disord; 2000 Mar; 2(1):37-41. PubMed ID: 11254018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.
    Löfgren E; Mikkonen K; Tolonen U; Pakarinen A; Koivunen R; Myllyla VV; Tapanainen JS; Isojärvi JI
    Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case reports.
    Betts T
    Seizure; 2001 Apr; 10(3):229-34. PubMed ID: 11437624
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome and valproic acid].
    Ribacoba Montero R; Martínez-Faedo C; Salas-Puig J
    Rev Neurol; 2003 Nov 16-30; 37(10):975-82. PubMed ID: 14634930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered ovarian function and cardiovascular risk factors in valproate-treated women.
    Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS
    Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.